Home
About
Pricing
Log In
Back
3DA
Asset Logo

Amaero Ltd

๐Ÿ‡ฆ๐Ÿ‡บ ASX

๐Ÿšœ MACHINERY

Compare
Add to watchlist
๐Ÿ‘‘ Overview

๐Ÿ“ˆ Performance

๐Ÿ’ต Cost

๐Ÿค“ Advanced

๐Ÿ‘จโ€๐Ÿ‘ฉโ€๐Ÿ‘งโ€๐Ÿ‘ฆ Community

๐Ÿ“ˆ

-11.45%
Annual Growth

5 years average annual capital growth

๐Ÿ’ต

$ 500
Minimum Order

Due to regulatory requirements

๐ŸŒ

16
Pearlers Invested

Since January 2020

๐Ÿ‘‘ Overview

Key information
๐Ÿ”Ž Fund Overview

Amaero Ltd. engages in manufacturing of large format complex components in metal using laser-based additive manufacturing processes. The company is headquartered in Melbourne, Victoria. The company went IPO on 2019-12-06. The firm has commissioned advanced gas atomization technology with a yield of AM powder. The firm is also engaged in PM-HIP (Powder Metallurgy Hot Isostatic Pressing) manufacturing of large, near-net-shape powder metallurgy parts with forged-equivalent material properties and microstructure for a variety of alloys. PM-HIP manufacturing helps alleviate the strained domestic supply chain for large-scale castings and forgings. Its refractory powders are engineered for extreme environments, with high-temperature-resistant materials like C103, titanium, niobium, molybdenum, tungsten, and tantalum. The firm also serves markets, including oil and gas, industrial, heavy industry, medical, and energy.

๐Ÿ“ˆ Performance

Price History

-26.25%

1M

1Y

All Time

Graph

Table

Unsure how much or often to invest?
๐Ÿ—“๏ธ Investing frequency calculator

Determine the investment frequency needed to reach your goals

Try it out โ†’
๐Ÿ’ต Investing amount calculator

Determine the recurring investment needed to reach your goals

Try it out โ†’
โฑ๏ธ Investing duration calculator

Determine how long you will need to invest to reach your goals

Try it out โ†’

๐Ÿ’ต Costs

๐Ÿ’ต

6.50 AUD*
Purchase Fee

*$5.50 with Pearler Prepay

๐Ÿ’ผ

N/A
Management Fee

Included in unit price, not charged by Pearler

๐Ÿ’ธ

Want to know the long term costs?
Calculate the historic long term costs to hold your investments
๐Ÿ’ธ Net fee calculator

๐Ÿค“ Advanced information

Technical Info

๐Ÿ’ฐ Price*

$0.29

*Price may be up to 24 hours old

๐Ÿ‘ฉโ€๐Ÿ‘ฉโ€๐Ÿ‘ฆ Community Insights

How our community is investing

๐ŸŒ Pearlers invested in 3DA

16

๐Ÿ“Š Total Capital Earnings

$19K

๐Ÿ”ƒ Average investment frequency

49 weeks

๐Ÿ’ต Average investment amount

$980

โฐ Last time a customer invested in 3DA

6 days
3DA investor breakdown
๐Ÿ’ต Income of investors

More than 200k

150k - 200k

20%

100k - 150k

10%

50k - 100k

30%

Less than 50k

35%
๐Ÿ‘ถ Age of investors

18 - 25

26 - 34

35 - 90

88%
๐Ÿ™‹ Legal gender of investors

Female

31%

Male

69%

Pearlers who invest in 3DA also invest in...

Vanguard Australian Shares Index ETF

VAS

VAS.AX was created on 2009-05-04 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard Australian Shares Index ETF seeks to track the return of the S&P/ASX 300 Index before taking into account fees, expenses and tax.

๐Ÿ™Œ Performance (5Yr p.a)

8.10%

๐Ÿ“Š Share price

$111.13 AUD

๐Ÿ’ธ FINANCIALS

โ›ณ๏ธ DIVERSIFIED

๐Ÿ‡ฆ๐Ÿ‡บ AUSTRALIA

๐Ÿ“ˆ HIGH PRICE GROWTH

๐Ÿงฑ MATERIALS

Find Out More

DroneShield Ltd. engages in the development and commercialisation of hardware and software technology for drone detection and security. The company is headquartered in Sydney, New South Wales. The company went IPO on 2016-06-22. The company provides artificial intelligence-based platforms for protection against advanced threats, such as drones and autonomous systems. The company offers customers bespoke counter-drone (or counter-UAS) and electronic warfare solutions and off-the-shelf products designed to suit a variety of terrestrial, maritime, or airborne platforms. The Companyโ€™s products include DroneGun Tactical, DroneGun MKIII, DroneSentry, DroneSentry-C2, DroneSentry-X, RfPatrol and DroneSim among others. The DroneGun Tactical is an unmanned aerial systems (UAS) countermeasure designed for two-hand operation and long-range defeat. RfPatrol is a passive/non-emitting wearable UAS detection device. The Companyโ€™s capabilities include C-UAS, C-UxS Training, and Electronic Warfare.

๐Ÿ™Œ Performance (5Yr p.a)

600.49%

๐Ÿ“Š Share price

$6.36 AUD

๐Ÿš€ AEROSPACE & DEFENSE

VGS.AX was created on 2014-11-18 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard MSCI International Shares Index ETF seeks to track the return of the MSCI World ex-Australia Index (with net dividends reinvested) in Australian dollars before taking into account fees, expenses and tax.

๐Ÿ™Œ Performance (5Yr p.a)

16.80%

๐Ÿ“Š Share price

$152.37 AUD

โ›ณ๏ธ DIVERSIFIED

๐Ÿ“ˆ HIGH PRICE GROWTH

๐Ÿค– TECHNOLOGY

๐ŸŒ GLOBAL

IVV.AX was created on 2000-05-15 by iShares. The fund's investment portfolio concentrates primarily on large cap equity. The Fund aims to provide investors with the performance of an index, before fees and expenses. The index is designed to measure the performance of large capitalisation US equities.

๐Ÿ™Œ Performance (5Yr p.a)

21.69%

๐Ÿ“Š Share price

$68.31 AUD

๐Ÿ“ˆ HIGH PRICE GROWTH

๐Ÿ‡บ๐Ÿ‡ธ UNITED STATES

Botanix Pharmaceuticals Ltd. is a dermatology company, which engages in the provision of business of researching and developing dermatology and antimicrobial products. The company is headquartered in Perth, Western Australia. The Companyโ€™s lead product is Sofdra (sofpironium) topical gel, 12.45%, a prescription anticholinergic medicine used on the skin (topical), to treat excessive underarm sweating (primary axillary hyperhidrosis) in adults and children nine years of age and older. Sofdra regulates sweating at the site of application, by binding to the primary sweat receptor and thereby blocking the sweat signal. Its product pipeline targets the various skin diseases, such as BTX 1503 for Acne, BTX 1702 for Rosacea, BTX 1204A for Atopic Dermatitis, and BTX 1801 for Hemodialysis Patients. Its BTX 1503 is a transdermal gel formulation for the treatment of serious acne in adults and teenagers. BTX 1702 is used for the treatment of papulopustular rosacea. BTX 1801 is an antimicrobial gel focused on targeting Staphylococcus Aureus and Methicillin Resistant Staphylococcus Aureus (MRSA).

๐Ÿ™Œ Performance (5Yr p.a)

6.36%

๐Ÿ“Š Share price

$0.14 AUD

๐Ÿ“ฆ LOGISTICS

Want more shares? Try these...

3DAAJ

Compare
Add to watchlist